Other cardiovascular outcomes, including the incidences of revascularization, hemorrhagic stroke, death from cardiovascular causes, and death from any causes were not significantly associated with any demographic factor, stroke etiology group, or CD62E+ microparticle level (data not shown). The gene discussed is SELE; the disease is hemorrhagic stroke.